Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Organon & Co. (OGN : NYSE)

• Company Description    Organon is a healthcare company. It focuses on the health of women throughout their lives. Organon is based in JERSEY CITY, N.J. Number of Employees: 4,000

• Price / Volume Information    Yesterday's Closing Price: $9.94 Daily Weekly Monthly 20 Day Moving Average: 3,305,663 shares Shares Outstanding: 259.96 (millions) Market Capitalization: $2,583.96 (millions) Beta: 0.60 52 Week High: $23.10 52 Week Low: $8.01 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -1.00% -5.47% 12 Week -10.61% -24.56% Year To Date -33.38% -37.40%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 30 Hudson Street FL 33 - Jersey City,NJ 07302 USA ph: 551-430-6900 fax: - investor_relations@organon.com http://www.organon.com

• General Corporate Information    Officers Kevin Ali - Chief Executive Officer Carrie Cox - Chairman of the Board of Directors Matthew Walsh - Chief Financial Officer Kathryn DiMarco - SVP Finance - Corporate Controller Robert Essner - Director Peer Information Organon & Co. (CHCR) Organon & Co. (ESRX) Organon & Co. (MYDP) Organon & Co. (COR) Organon & Co. (GBCS) Organon & Co. (LAXAF) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: Medical Services Sector: Medical CUSIP: 68622V106 SIC: 2834 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/25 Next Expected EPS Date: 08/05/25 Share - Related Items Shares Outstanding: 259.96 Most Recent Split Date: (:1) Beta: 0.60 Market Capitalization: $2,583.96 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.80% Current Fiscal Quarter EPS Consensus Estimate: $0.90 Indicated Annual Dividend: $0.08 Current Fiscal Year EPS Consensus Estimate: $3.72 Payout Ratio: 0.31 Number of Estimates in the Fiscal Year Consensus: 3.00 Change In Payout Ratio: 0.06 Estmated Long-Term EPS Growth Rate: 2.63% Last Dividend Paid: 05/12/2025 - $0.02 Next EPS Report Date: 08/05/25

• Fundamental Ratios P/E Current FY Estimate: 2.67 Trailing 12 Months: 2.75 PEG Ratio: 1.02 Price Ratios Price/Book: 4.77 Price/Cash Flow: 2.02 Price / Sales: 0.41 EPS Growth vs. Year Ago Period: -16.67% vs. Previous Quarter: 14.46% Sales Growth vs. Year Ago Period: -6.72% vs. Previous Quarter: -4.96% ROE 06/30/25 - - 03/31/25 - 227.43 12/31/24 - 340.72 ROA 06/30/25 - - 03/31/25 - 7.34 12/31/24 - 7.90 Current Ratio 06/30/25 - - 03/31/25 - 1.67 12/31/24 - 1.60 Quick Ratio 06/30/25 - - 03/31/25 - 1.15 12/31/24 - 1.11 Operating Margin 06/30/25 - - 03/31/25 - 14.91 12/31/24 - 15.39 Net Margin 06/30/25 - - 03/31/25 - 11.92 12/31/24 - 13.49 Pre-Tax Margin 06/30/25 - - 03/31/25 - 10.68 12/31/24 - 12.60 Book Value 06/30/25 - - 03/31/25 - 2.09 12/31/24 - 1.83 Inventory Turnover 06/30/25 - - 03/31/25 - 2.01 12/31/24 - 2.05 Debt-to-Equity 06/30/25 - - 03/31/25 - 16.49 12/31/24 - 18.77 Debt-to-Capital 06/30/25 - - 03/31/25 - 94.28 12/31/24 - 94.94

Powered by Zacks Investment Research ©